TE BIOS CO., LTD. is a South Korean biotechnology company founded in 2009, specializing in translational research in regenerative medicine, including stem cells and scaffold technologies. The company develops and commercializes products for skin renewal, anti-aging, and health foods. Notably, TE BIOS has launched CorriX, a nutraceutical with an anti-cancer immune surveillance function, and has received innovative medical device designation for its artificial cornea, C-Clear.